Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
2021 · OncoTargets and Therapy · 14 citations
https://doi.org/10.2147/ott.s318082
H
Hui Zhang
BC Cancer Agency(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
9.1K
Citations
27
h-index
44
i10-index
Hui Zhang is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: Cancer-related Molecular Pathways & CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 27, co-authored 121 publications.
ORCID: 0000-0002-7410-6516Papers by this author
worksT cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis
2021 · Diagnostic Pathology · 13 citations
https://doi.org/10.1186/s13000-021-01139-7
Establishment and characterization of CHC-X1: the third human combined hepatocellular–cholangiocarcinoma cell line
2025 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-025-13876-9
Identification of potential prognostic biomarkers in vulval squamous cell carcinoma based on human papillomavirus infection Status-Analysis of GSE183454
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21941503
A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma
2024 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-024-56464-w
Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line
2024 · Human Cell · 0 citations
https://doi.org/10.1007/s13577-024-01100-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat